La cadena de opciones muestra datos clave de las opciones de acciones de Innoviz Technologies a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Innoviz Technologies..

Innoviz Technologies (NASDAQ:INVZ) Bolsa, Cadena de Opciones

Innoviz Technologies

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

News

Offerings

ALVO

Alvotech SA Files For Mixed Shelf; Size Not Disclosed

<p><strong>Okeanis Eco Tankers</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECO#NYSE">ECO</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-05-14. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Okeanis Eco Tankers will report an <strong>earnings per share</strong> (EPS) of $0.24. </p>
<p>The announcement from Okeanis Eco Tankers is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $0.19, leading to a 6.77% drop in the share price the following trading session.</p>
<p>Here's a look at Okeanis Eco Tankers's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.24</td>
<td>0.22</td>
<td>0.09</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.36</td>
<td>0.41</td>
<td>0.45</td>
<td>1.23</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-4.0%</td>
<td>-7.000000000000001%</td>
<td>-8.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<h3>Stock Performance</h3>
<p>Shares of Okeanis Eco Tankers were trading at $23.99 as of July 25. Over the last 52-week period, shares are down 22.55%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analysts' Perspectives on Okeanis Eco Tankers</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Okeanis Eco Tankers.</p>
<p>Analysts have given Okeanis Eco Tankers a total of 1 ratings, with the consensus rating being Buy. The average one-year price target is $29.0, indicating a potential 20.88% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Tsakos Energy Navigation, Nordic American Tankers and New Fortress Energy, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Tsakos Energy Navigation, with an average 1-year price target of $21.0, suggesting a potential 12.46% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Nordic American Tankers, with an average 1-year price target of $3.0, suggesting a potential 87.49% downside.</li>
<li>Analysts currently favor an Buy trajectory for New Fortress Energy, with an average 1-year price target of $6.25, suggesting a potential 73.95% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>The peer analysis summary presents essential metrics for Tsakos Energy Navigation, Nordic American Tankers and New Fortress Energy, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Excelerate Energy</td>
<td>Buy</td>
<td>57.46%</td>
<td>$90.75M</td>
<td>9.92%</td>
</tr>
<tr>
<td>Tsakos Energy Navigation</td>
<td>Neutral</td>
<td>-2.25%</td>
<td>$66.97M</td>
<td>1.78%</td>
</tr>
<tr>
<td>Nordic American Tankers</td>
<td>Neutral</td>
<td>-37.36%</td>
<td>$8.20M</td>
<td>0.84%</td>
</tr>
<tr>
<td>New Fortress Energy</td>
<td>Buy</td>
<td>-31.84%</td>
<td>$107.93M</td>
<td>-11.04%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Okeanis Eco Tankers ranks at the top for Revenue Growth and Gross Profit among its peers. However, it ranks at the bottom for Return on Equity. Overall, Okeanis Eco Tankers shows strong revenue growth and gross profit performance compared to its peers, but lags behind in terms of return on equity.</p>
<h3>About Okeanis Eco Tankers</h3>
<p>Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers and eight VLCC tankers.</p>
<h3>Key Indicators: Okeanis Eco Tankers's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Okeanis Eco Tankers faced challenges, resulting in a decline of approximately <strong>-27.88%</strong> in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Okeanis Eco Tankers's net margin excels beyond industry benchmarks, reaching <strong>15.67%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Okeanis Eco Tankers's ROE excels beyond industry benchmarks, reaching <strong>3.05%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Okeanis Eco Tankers's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.17%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Okeanis Eco Tankers's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>1.54</strong>.</p>
<p><a href="https://www.benzinga.com/quote/ECO/earnings"><strong>To track all earnings releases for Okeanis Eco Tankers visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

An Overview of Okeanis Eco Tankers's Earnings

<p>Expro Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPRO#NYSE">XPRO</a>) is preparing to release its quarterly earnings on Tuesday, 2025-07-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Expro Gr Hldgs to report an <strong>earnings per share</strong> (EPS) of $0.16.</p>
<p>The announcement from Expro Gr Hldgs is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.14, which was followed by a 0.73% increase in the share price the next day.</p>
<p>Here's a look at Expro Gr Hldgs's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.11</td>
<td>0.31</td>
<td>0.26</td>
<td>0.27</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.25</td>
<td>0.36</td>
<td>0.23</td>
<td>0.27</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-7.000000000000001%</td>
<td>-5.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736571_0.png" alt="eps graph" /></p>
<h3>Expro Gr Hldgs Share Price Analysis</h3>
<p>Shares of Expro Gr Hldgs were trading at $8.65 as of July 25. Over the last 52-week period, shares are down 59.46%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/XPRO/earnings"><strong>To track all earnings releases for Expro Gr Hldgs visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


XPRO

A Look at Expro Gr Hldgs's Upcoming Earnings Report

<p>Tetra Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) is preparing to release its quarterly earnings on Tuesday, 2025-07-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Tetra Technologies to report an <strong>earnings per share</strong> (EPS) of $0.08.</p>
<p>The announcement from Tetra Technologies is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Past Earnings Performance</h3>
<p>The company's EPS beat by $0.03 in the last quarter, leading to a 3.26% increase in the share price on the following day.</p>
<p>Here's a look at Tetra Technologies's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.08</td>
<td>0.03</td>
<td>0.04</td>
<td>0.10</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.11</td>
<td>0.03</td>
<td>0.03</td>
<td>0.07</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>-4.0%</td>
<td>23.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736564_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Tetra Technologies were trading at $3.72 as of July 25. Over the last 52-week period, shares are up 3.87%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analysts' Perspectives on Tetra Technologies</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Tetra Technologies.</p>
<p>Analysts have given Tetra Technologies a total of 2 ratings, with the consensus rating being Buy. The average one-year price target is $5.0, indicating a potential 34.41% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Oil States International, ProPetro Holding and National Energy Services, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Oil States International, with an average 1-year price target of $5.5, suggesting a potential 47.85% upside.</li>
<li>Analysts currently favor an Buy trajectory for ProPetro Holding, with an average 1-year price target of $8.75, suggesting a potential 135.22% upside.</li>
<li>Analysts currently favor an Outperform trajectory for National Energy Services, with an average 1-year price target of $11.0, suggesting a potential 195.7% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>In the peer analysis summary, key metrics for Oil States International, ProPetro Holding and National Energy Services are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tetra Technologies</td>
<td>Buy</td>
<td>4.09%</td>
<td>$42.91M</td>
<td>1.54%</td>
</tr>
<tr>
<td>Oil States International</td>
<td>Neutral</td>
<td>-4.38%</td>
<td>$25.24M</td>
<td>0.45%</td>
</tr>
<tr>
<td>ProPetro Holding</td>
<td>Buy</td>
<td>-11.44%</td>
<td>$46.88M</td>
<td>1.17%</td>
</tr>
<tr>
<td>National Energy Services</td>
<td>Outperform</td>
<td>2.11%</td>
<td>$37.45M</td>
<td>1.14%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Tetra Technologies ranks highest in revenue growth among its peers. It also leads in gross profit margin. However, it has the lowest return on equity compared to its peers.</p>
<h3>Delving into Tetra Technologies's Background</h3>
<p>Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids &amp; Products, and Water &amp; Flowback Services. The Completion Fluids &amp; Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids &amp; Products. The company derives maximum revenue from United states.</p>
<h3>Breaking Down Tetra Technologies's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Tetra Technologies's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>4.09%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.</p>
<p><strong>Net Margin:</strong> Tetra Technologies's net margin excels beyond industry benchmarks, reaching <strong>2.58%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Tetra Technologies's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>1.54%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>0.66%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Tetra Technologies's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>0.79</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<p><a href="https://www.benzinga.com/quote/TTI/earnings"><strong>To track all earnings releases for Tetra Technologies visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Preview Of Tetra Technologies's Earnings

<p><strong>Teladoc Health</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-07-29. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Teladoc Health will report an <strong>earnings per share</strong> (EPS) of $-0.29. </p>
<p>Investors in Teladoc Health are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.17 in the last quarter, leading to a 2.78% drop in the share price on the following day.</p>
<p>Here's a look at Teladoc Health's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.36</td>
<td>-0.29</td>
<td>-0.27</td>
<td>-0.34</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.19</td>
<td>-0.28</td>
<td>-0.19</td>
<td>-0.28</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>-14.000000000000002%</td>
<td>2.0%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736555_0.png" alt="eps graph" /></p>
<h3>Tracking Teladoc Health's Stock Performance</h3>
<p>Shares of Teladoc Health were trading at $8.2 as of July 25. Over the last 52-week period, shares are down 15.72%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Observations about Teladoc Health</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Teladoc Health.</p>
<p>Teladoc Health has received a total of 9 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $8.78, the consensus suggests a potential 7.07% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Phreesia, Schrodinger and Evolent Health, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Phreesia, with an average 1-year price target of $34.67, suggesting a potential 322.8% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Schrodinger, with an average 1-year price target of $30.0, suggesting a potential 265.85% upside.</li>
<li>Analysts currently favor an Buy trajectory for Evolent Health, with an average 1-year price target of $14.75, suggesting a potential 79.88% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Phreesia, Schrodinger and Evolent Health, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Teladoc Health</td>
<td>Neutral</td>
<td>-2.59%</td>
<td>$432.54M</td>
<td>-6.37%</td>
</tr>
<tr>
<td>Phreesia</td>
<td>Buy</td>
<td>14.54%</td>
<td>$77.87M</td>
<td>-1.43%</td>
</tr>
<tr>
<td>Schrodinger</td>
<td>Outperform</td>
<td>62.72%</td>
<td>$31.12M</td>
<td>-15.05%</td>
</tr>
<tr>
<td>Evolent Health</td>
<td>Buy</td>
<td>-24.39%</td>
<td>$102.47M</td>
<td>-7.46%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Teladoc Health ranks at the bottom for Revenue Growth and Gross Profit, while it is in the middle for Return on Equity. The company's Consensus rating is Neutral.</p>
<h3>About Teladoc Health</h3>
<p>Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.</p>
<h3>Financial Insights: Teladoc Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Teladoc Health's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately <strong>-2.59%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> Teladoc Health's net margin is impressive, surpassing industry averages. With a net margin of <strong>-14.78%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Teladoc Health's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>-6.37%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Teladoc Health's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>-2.67%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.11</strong>.</p>
<p><a href="https://www.benzinga.com/quote/TDOC/earnings"><strong>To track all earnings releases for Teladoc Health visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


TDOC

Insights Ahead: Teladoc Health's Quarterly Earnings

As Of May 31, 2025, Nike Had Product Purchase Obligations Of About $5B

<p><strong>NexPoint Residential</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXRT#NYSE">NXRT</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-07-29. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that NexPoint Residential will report an <strong>earnings per share</strong> (EPS) of $0.07. </p>
<p>Anticipation surrounds NexPoint Residential's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed EPS by $0.02, which was followed by a 0.29% drop in the share price the next day.</p>
<p>Here's a look at NexPoint Residential's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.77</td>
<td>0.80</td>
<td>0.76</td>
<td>0.79</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.75</td>
<td>0.68</td>
<td>0.69</td>
<td>0.68</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>0.0%</td>
<td>-1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736544_0.png" alt="eps graph" /></p>
<h3>NexPoint Residential Share Price Analysis</h3>
<p>Shares of NexPoint Residential were trading at $33.85 as of July 25. Over the last 52-week period, shares are down 24.55%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analyst Observations about NexPoint Residential</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on NexPoint Residential.</p>
<p>NexPoint Residential has received a total of 2 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $40.25, the consensus suggests a potential 18.91% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Center, Veris Residential and Independence Realty Trust, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Center, with an average 1-year price target of $67.25, suggesting a potential 98.67% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Veris Residential, with an average 1-year price target of $18.67, suggesting a potential 44.84% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Independence Realty Trust, with an average 1-year price target of $22.5, suggesting a potential 33.53% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary presents essential metrics for Center, Veris Residential and Independence Realty Trust, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>NexPoint Residential</td>
<td>Neutral</td>
<td>-6.45%</td>
<td>$36.23M</td>
<td>-1.75%</td>
</tr>
<tr>
<td>Center</td>
<td>Neutral</td>
<td>4.01%</td>
<td>$37.93M</td>
<td>-0.58%</td>
</tr>
<tr>
<td>Veris Residential</td>
<td>Neutral</td>
<td>12.53%</td>
<td>$46.74M</td>
<td>1.01%</td>
</tr>
<tr>
<td>Independence Realty Trust</td>
<td>Neutral</td>
<td>0.44%</td>
<td>$94.15M</td>
<td>0.24%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>NexPoint Residential ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit. However, it is at the top for Return on Equity.</p>
<h3>All You Need to Know About NexPoint Residential</h3>
<p>NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.</p>
<h3>Financial Insights: NexPoint Residential</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Negative Revenue Trend:</strong> Examining NexPoint Residential's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately <strong>-6.45%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.</p>
<p><strong>Net Margin:</strong> NexPoint Residential's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-10.91%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> NexPoint Residential's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-1.75%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> NexPoint Residential's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-0.36%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> NexPoint Residential's debt-to-equity ratio surpasses industry norms, standing at <strong>3.86</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<p><a href="https://www.benzinga.com/quote/NXRT/earnings"><strong>To track all earnings releases for NexPoint Residential visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


NXRT

A Look at NexPoint Residential's Upcoming Earnings Report

<p>LendingClub (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) is preparing to release its quarterly earnings on Tuesday, 2025-07-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect LendingClub to report an <strong>earnings per share</strong> (EPS) of $0.15.</p>
<p>Anticipation surrounds LendingClub's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed EPS by $0.01, which was followed by a 11.26% drop in the share price the next day.</p>
<p>Here's a look at LendingClub's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.11</td>
<td>0.09</td>
<td>0.07</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.10</td>
<td>0.08</td>
<td>0.13</td>
<td>0.13</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-11.0%</td>
<td>-14.000000000000002%</td>
<td>11.0%</td>
<td>12.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736534_0.png" alt="eps graph" /></p>
<h3>Tracking LendingClub's Stock Performance</h3>
<p>Shares of LendingClub were trading at $12.83 as of July 25. Over the last 52-week period, shares are up 15.73%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/LC/earnings"><strong>To track all earnings releases for LendingClub visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


LendingClub Earnings Preview

<p>ConnectOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNOB#NASDAQ">CNOB</a>) will release its quarterly earnings report on Tuesday, 2025-07-29. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate ConnectOne Bancorp to report an <strong>earnings per share</strong> (EPS) of $0.56.</p>
<p>Anticipation surrounds ConnectOne Bancorp's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the last quarter, the company reported an EPS beat by $0.05, leading to a 1.8% drop in the share price on the subsequent day.</p>
<p>Here's a look at ConnectOne Bancorp's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.46</td>
<td>0.43</td>
<td>0.44</td>
<td>0.41</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.51</td>
<td>0.52</td>
<td>0.41</td>
<td>0.46</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>1.0%</td>
<td>-2.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736524_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of ConnectOne Bancorp were trading at $24.25 as of July 25. Over the last 52-week period, shares are up 0.91%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/CNOB/earnings"><strong>To track all earnings releases for ConnectOne Bancorp visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


CNOB

A Peek at ConnectOne Bancorp's Future Earnings

<p><strong>Clearwater Paper</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-07-29. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Clearwater Paper will report an <strong>earnings per share</strong> (EPS) of $0.70. </p>
<p>The market awaits Clearwater Paper's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company missed EPS by $0.34, which was followed by a 7.4% increase in the share price the next day.</p>
<p>Here's a look at Clearwater Paper's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.33</td>
<td>0.29</td>
<td>0.30</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.38</td>
<td>-1.17</td>
<td>0.35</td>
<td>-0.53</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>7.000000000000001%</td>
<td>-8.0%</td>
<td>11.0%</td>
<td>-21.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736514_0.png" alt="eps graph" /></p>
<h3>Market Performance of Clearwater Paper's Stock</h3>
<p>Shares of Clearwater Paper were trading at $30.84 as of July 25. Over the last 52-week period, shares are down 46.88%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/CLW/earnings"><strong>To track all earnings releases for Clearwater Paper visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Clearwater Paper's Earnings: A Preview

Occidental Petroleum Announces Mixed Shelf; Size Not Disclosed

<p>Community Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHCT#NYSE">CHCT</a>) will release its quarterly earnings report on Tuesday, 2025-07-29. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Community Healthcare to report an <strong>earnings per share</strong> (EPS) of $0.15.</p>
<p>The announcement from Community Healthcare is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company beat EPS by $0.02, leading to a 5.04% increase in the share price the following trading session.</p>
<p>Here's a look at Community Healthcare's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.53</td>
<td>0.54</td>
<td>0.52</td>
<td>0.60</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.55</td>
<td>0.55</td>
<td>0.55</td>
<td>0.53</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>5.0%</td>
<td>-6.0%</td>
<td>7.000000000000001%</td>
<td>-21.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736506_0.png" alt="eps graph" /></p>
<h3>Performance of Community Healthcare Shares</h3>
<p>Shares of Community Healthcare were trading at $16.56 as of July 25. Over the last 52-week period, shares are down 40.53%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Observations about Community Healthcare</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Community Healthcare.</p>
<p>Analysts have given Community Healthcare a total of 1 ratings, with the consensus rating being Neutral. The average one-year price target is $18.0, indicating a potential 8.7% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Global Medical REIT, Strawberry Fields REIT and LTC Properties, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Global Medical REIT, with an average 1-year price target of $9.0, suggesting a potential 45.65% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Strawberry Fields REIT, with an average 1-year price target of $10.65, suggesting a potential 35.69% downside.</li>
<li>Analysts currently favor an Neutral trajectory for LTC Properties, with an average 1-year price target of $36.0, suggesting a potential 117.39% upside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>Within the peer analysis summary, vital metrics for Global Medical REIT, Strawberry Fields REIT and LTC Properties are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Community Healthcare</td>
<td>Neutral</td>
<td>2.54%</td>
<td>$23.98M</td>
<td>0.18%</td>
</tr>
<tr>
<td>Global Medical REIT</td>
<td>Neutral</td>
<td>-1.35%</td>
<td>$27.01M</td>
<td>0.47%</td>
</tr>
<tr>
<td>Strawberry Fields REIT</td>
<td>Neutral</td>
<td>34.13%</td>
<td>$33.53M</td>
<td>8.38%</td>
</tr>
<tr>
<td>LTC Properties</td>
<td>Neutral</td>
<td>-4.55%</td>
<td>$45.92M</td>
<td>2.13%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Community Healthcare is positioned in the middle among its peers for Consensus rating. It ranks at the bottom for Revenue Growth. In terms of Gross Profit, it is at the bottom compared to its peers. However, it is at the top for Return on Equity among the listed companies.</p>
<h3>Get to Know Community Healthcare Better</h3>
<p>Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.</p>
<h3>A Deep Dive into Community Healthcare's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Community Healthcare showcased positive performance, achieving a revenue growth rate of <strong>2.54%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.</p>
<p><strong>Net Margin:</strong> Community Healthcare's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>2.77%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Community Healthcare's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>0.18%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.08%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>1.08</strong>, Community Healthcare adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/CHCT/earnings"><strong>To track all earnings releases for Community Healthcare visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


CHCT

Community Healthcare Earnings Preview

<p>BlueLinx Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXC#NYSE">BXC</a>) will release its quarterly earnings report on Tuesday, 2025-07-29. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate BlueLinx Hldgs to report an <strong>earnings per share</strong> (EPS) of $1.06.</p>
<p>BlueLinx Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.01 in the last quarter, leading to a 9.94% drop in the share price on the following day.</p>
<p>Here's a look at BlueLinx Hldgs's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.26</td>
<td>0.52</td>
<td>1.19</td>
<td>1.74</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.27</td>
<td>0.61</td>
<td>1.95</td>
<td>1.68</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-10.0%</td>
<td>-8.0%</td>
<td>9.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736496_0.png" alt="eps graph" /></p>
<h3>Performance of BlueLinx Hldgs Shares</h3>
<p>Shares of BlueLinx Hldgs were trading at $80.05 as of July 25. Over the last 52-week period, shares are down 35.27%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analysts' Take on BlueLinx Hldgs</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on BlueLinx Hldgs.</p>
<p>A total of 3 analyst ratings have been received for BlueLinx Hldgs, with the consensus rating being Buy. The average one-year price target stands at $90.0, suggesting a potential 12.43% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Karat Packaging and NPK International, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Karat Packaging, with an average 1-year price target of $31.0, suggesting a potential 61.27% downside.</li>
<li>Analysts currently favor an Buy trajectory for NPK International, with an average 1-year price target of $12.0, suggesting a potential 85.01% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>In the peer analysis summary, key metrics for Karat Packaging and NPK International are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>BlueLinx Hldgs</td>
<td>Buy</td>
<td>-2.34%</td>
<td>$111.13M</td>
<td>0.44%</td>
</tr>
<tr>
<td>Karat Packaging</td>
<td>Neutral</td>
<td>8.38%</td>
<td>$40.76M</td>
<td>4.15%</td>
</tr>
<tr>
<td>NPK International</td>
<td>Buy</td>
<td>32.29%</td>
<td>$25.25M</td>
<td>3.06%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>BlueLinx Hldgs ranks at the bottom for Revenue Growth with a negative rate, while its peers show positive growth rates. In terms of Gross Profit, BlueLinx Hldgs has the highest value among its peers. However, its Return on Equity is the lowest compared to the others. Overall, BlueLinx Hldgs lags behind its peers in Revenue Growth and Return on Equity but leads in Gross Profit.</p>
<h3>About BlueLinx Hldgs</h3>
<p>BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.</p>
<h3>A Deep Dive into BlueLinx Hldgs's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Challenges:</strong> BlueLinx Hldgs's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately <strong>-2.34%</strong>. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> BlueLinx Hldgs's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>0.4%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> BlueLinx Hldgs's ROE excels beyond industry benchmarks, reaching <strong>0.44%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> BlueLinx Hldgs's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>0.17%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> BlueLinx Hldgs's debt-to-equity ratio is below the industry average. With a ratio of <b>1.04</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/BXC/earnings"><strong>To track all earnings releases for BlueLinx Hldgs visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Exploring BlueLinx Hldgs's Earnings Expectations

<p>Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.99 by 3.83 percent. This is a 10.75 percent increase over earnings of $0.93 per share from the same period last year.  The company reported quarterly sales of $1.285 billion which beat the analyst consensus estimate of $1.277 billion by 0.65 percent.  This is a 9.08 percent increase over sales of $1.178 billion the same period last year.</p>


Earnings Beats

Brown & Brown Q2 Adj. EPS $1.03 Beats $0.99 Estimate, Sales $1.285B Beat $1.277B Estimate

<p>Werner Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WERN#NASDAQ">WERN</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-07-29. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Werner Enterprises will report an <strong>earnings per share</strong> (EPS) of $0.05.</p>
<p>Werner Enterprises bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company missed EPS by $0.24, leading to a 10.85% drop in the share price the following trading session.</p>
<p>Here's a look at Werner Enterprises's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.12</td>
<td>0.22</td>
<td>0.21</td>
<td>0.21</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.12</td>
<td>0.08</td>
<td>0.15</td>
<td>0.17</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-11.0%</td>
<td>-1.0%</td>
<td>-3.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736482_0.png" alt="eps graph" /></p>
<h3>Performance of Werner Enterprises Shares</h3>
<p>Shares of Werner Enterprises were trading at $29.33 as of July 25. Over the last 52-week period, shares are down 29.25%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<h3>Analyst Insights on Werner Enterprises</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Werner Enterprises.</p>
<p>The consensus rating for Werner Enterprises is Neutral, based on 13 analyst ratings. With an average one-year price target of $26.54, there's a potential 9.51% downside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of ArcBest, Universal Logistics Hldgs and RXO, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for ArcBest, with an average 1-year price target of $80.43, suggesting a potential 174.22% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Universal Logistics Hldgs, with an average 1-year price target of $29.0, suggesting a potential 1.13% downside.</li>
<li>Analysts currently favor an Neutral trajectory for RXO, with an average 1-year price target of $16.5, suggesting a potential 43.74% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for ArcBest, Universal Logistics Hldgs and RXO, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Werner Enterprises</td>
<td>Neutral</td>
<td>-7.41%</td>
<td>$69.57M</td>
<td>-0.70%</td>
</tr>
<tr>
<td>ArcBest</td>
<td>Neutral</td>
<td>-6.69%</td>
<td>$55.51M</td>
<td>0.24%</td>
</tr>
<tr>
<td>Universal Logistics Hldgs</td>
<td>Neutral</td>
<td>2.98%</td>
<td>$40.08M</td>
<td>1.28%</td>
</tr>
<tr>
<td>RXO</td>
<td>Neutral</td>
<td>56.96%</td>
<td>$200M</td>
<td>-1.94%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Werner Enterprises ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p>
<h3>Unveiling the Story Behind Werner Enterprises</h3>
<p>Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.</p>
<h3>Breaking Down Werner Enterprises's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Werner Enterprises faced challenges, resulting in a decline of approximately <strong>-7.41%</strong> in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>-1.42%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Werner Enterprises's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-0.7%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Werner Enterprises's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-0.33%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.45</strong>.</p>
<p><a href="https://www.benzinga.com/quote/WERN/earnings"><strong>To track all earnings releases for Werner Enterprises visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


WERN

Earnings Outlook For Werner Enterprises

<p>Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Accenture and provided 12-month price targets. The average target is $331.0, accompanied by a high estimate of $395.00 and a low estimate of $240.00. This current average has decreased by 9.34% from the previous average price target of $365.12. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736479_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The standing of Accenture among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Phani Kanumuri</td>
<td>HSBC</td>
<td>Announces</td>
<td>Reduce</td>
<td>$240.00</td>
<td>-</td>
</tr>
<tr>
<td>Bryan Keane</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Hold</td>
<td>$290.00</td>
<td>-</td>
</tr>
<tr>
<td>David Togut</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>Outperform</td>
<td>$330.00</td>
<td>-</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$325.00</td>
<td>$340.00</td>
</tr>
<tr>
<td>Dan Dolev</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$348.00</td>
<td>$365.00</td>
</tr>
<tr>
<td>Jonathan Lee</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$335.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Ramsey El-Assal</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$360.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$325.00</td>
<td>$355.00</td>
</tr>
<tr>
<td>Tien-Tsin Huang</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$353.00</td>
<td>$349.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$340.00</td>
<td>$372.00</td>
</tr>
<tr>
<td>Kevin Mcveigh</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$395.00</td>
<td>$390.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Accenture. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Accenture compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Accenture's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Accenture's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ACN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Accenture analyst ratings.</strong></a></p>
<h2>Get to Know Accenture Better</h2>
<p>Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.</p>
<h3>Breaking Down Accenture's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, Accenture showcased positive performance, achieving a revenue growth rate of <strong>7.66%</strong> as of 31 May, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Accenture's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>12.4%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Accenture's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>7.35%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Accenture's ROA excels beyond industry benchmarks, reaching <strong>3.57%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Accenture's debt-to-equity ratio is below the industry average at <strong>0.27</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

Expert Outlook: Accenture Through The Eyes Of 11 Analysts

<p>During the last three months, 6 analysts shared their evaluations of Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $18.5, a high estimate of $21.00, and a low estimate of $17.00. This upward trend is apparent, with the current average reflecting a 12.12% increase from the previous average price target of $16.50.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736469_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Capri Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Ashley Helgans</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$17.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$20.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$17.00</td>
<td>$17.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Capri Holdings. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Capri Holdings compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Capri Holdings's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Capture valuable insights into Capri Holdings's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CPRI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Capri Holdings analyst ratings.</strong></a></p>
<h2>Delving into Capri Holdings's Background</h2>
<p>Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. Capri also owns a third brand, Versace, but has agreed to sell it to Prada. John Idol has served as Capri's CEO since 2003.</p>
<h3>Capri Holdings's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Capri Holdings's revenue growth over a period of 3M has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately <strong>-15.37%</strong>. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Capri Holdings's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-62.32%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Capri Holdings's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-89.83%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Capri Holdings's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-11.6%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> Capri Holdings's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>8.43</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CPRI

Capri Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

General

CDNS

Cadence Design Systems Plea Agreement Includes Three-Year Probation; Obligations Under Bis Administrative Settlement Agreement Include Two Internal Annual Audits Of Export Compliance Programs

<p>KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) underwent analysis by 16 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $869.31, along with a high estimate of $1035.00 and a low estimate of $740.00. This upward trend is apparent, with the current average reflecting a 10.15% increase from the previous average price target of $789.20.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736457_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>A clear picture of KLA's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$750.00</td>
<td>$590.00</td>
</tr>
<tr>
<td>Timothy Arcuri</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$960.00</td>
<td>$775.00</td>
</tr>
<tr>
<td>James Schneider</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Neutral</td>
<td>$980.00</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Quatrochi</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$920.00</td>
<td>$870.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$1035.00</td>
<td>$835.00</td>
</tr>
<tr>
<td>Shane Brett</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$916.00</td>
<td>$868.00</td>
</tr>
<tr>
<td>Matthew Prisco</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$950.00</td>
<td>$800.00</td>
</tr>
<tr>
<td>Edward Yang</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$950.00</td>
<td>$740.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$900.00</td>
<td>$950.00</td>
</tr>
<tr>
<td>Shane Brett</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$868.00</td>
<td>$870.00</td>
</tr>
<tr>
<td>Matthew Prisco</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$800.00</td>
<td>$800.00</td>
</tr>
<tr>
<td>Brian Chin</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$770.00</td>
<td>$750.00</td>
</tr>
<tr>
<td>Krish Sankar</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$800.00</td>
<td>$770.00</td>
</tr>
<tr>
<td>Edward Yang</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$740.00</td>
<td>$700.00</td>
</tr>
<tr>
<td>Timothy Arcuri</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$740.00</td>
<td>$690.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$830.00</td>
<td>$830.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to KLA. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of KLA compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for KLA's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of KLA's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/KLAC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on KLA analyst ratings.</strong></a></p>
<h2>Get to Know KLA Better</h2>
<p>KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.</p>
<h3>KLA: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, KLA showcased positive performance, achieving a revenue growth rate of <strong>29.8%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>35.53%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> KLA's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>28.68%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> KLA's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>7.21%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> KLA's debt-to-equity ratio surpasses industry norms, standing at <strong>1.52</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


KLAC

KLA Stock: A Deep Dive Into Analyst Perspectives (16 Ratings)

<p>Weyerhaeuser (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.25, a high estimate of $35.00, and a low estimate of $29.00. A decline of 6.02% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753736446_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The standing of Weyerhaeuser among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Roxland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$29.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Kurt Yinger</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Hong Zhang</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Anthony Pettinari</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$31.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Weyerhaeuser. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Weyerhaeuser compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Weyerhaeuser's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Weyerhaeuser's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/WY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Weyerhaeuser analyst ratings.</strong></a></p>
<h2>Discovering Weyerhaeuser: A Closer Look</h2>
<p>Weyerhaeuser ranks among the world's largest forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.</p>
<h3>Weyerhaeuser: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Weyerhaeuser displayed positive results in 3M. As of 30 June, 2025, the company achieved a solid revenue growth rate of approximately <strong>6.86%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>4.62%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Weyerhaeuser's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>0.91%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Weyerhaeuser's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.53%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.54</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


4 Analysts Have This To Say About Weyerhaeuser

Press Releases

Innoviz Technologies Accelerates Delivery of Newly Designed LiDAR Platform to Volkswagen Autonomous Mobility to Equip a Fleet of ID. Buzz AD Shuttles in 2025

Small Cap

Innoviz Reports First Quarter 2025 Results

Innoviz Technologies Launches InnovizSMART, Bringing Automotive-Grade LiDAR Performance to Security, Mobility, Aerial, Robotics & Intelligent Traffic Management Applications

Comments

Innoviz Technologies

Innoviz Technologies (INVZ) Opciones

Innoviz Technologies (NASDAQ:INVZ) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL